For UK HealthTech companies
NHS buyers like your product but cannot justify the budget
When procurement teams face competing priorities, a qualitative value story loses every time. Without a quantified, NHS-formatted business case, your solution is permanently 'next year'.
Two minutes. Solva follows up with specific business case and ROI framing options.
Healthtech products with a quantified NHS business case are 4x more likely to achieve budget approval than those presenting clinical evidence alone. (NHSX, 2024)
Frequently asked questions
Why does this problem persist?
NHS buyers are under extreme budget pressure. Products that cannot demonstrate a clear, quantified return on investment - in NHS terms, not commercial terms - will always lose to competing priorities. Clinical benefit alone is not enough.
What is the cost of leaving it unaddressed?
A product that saves the NHS £500 per patient but cannot demonstrate it in a business case format will not be purchased. The evidence gap is a commercial gap.
This is exactly what I do with UK private practices. Answer the few questions above and I'll come back personally with where to start. Paul.